Enhancing Communication and HIV Outcomes
ECHO
2 other identifiers
interventional
186
1 country
3
Brief Summary
The goal of this research is to improve communication between the patients with HIV and their health care providers. The overall purpose of doing so is to reduce disparities in medication self-efficacy, adherence to therapy, and HIV viral load suppression. The investigators will conduct a randomized controlled trial to test the effectiveness of a combined provider and patient communication intervention conducted at two separate visits compared to usual care in improving the quality of patient-provider communication, patients' medication self-efficacy, patient adherence to therapy, and HIV RNA suppression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 hiv-infections
Started May 2008
Shorter than P25 for phase_3 hiv-infections
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 7, 2008
CompletedFirst Posted
Study publicly available on registry
May 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedApril 1, 2015
March 1, 2015
1 year
May 7, 2008
March 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patient-provider communication
1 day- 3 months
Study Arms (2)
usual care
NO INTERVENTIONproviders are not trained and patients are not coached
intervention arm
EXPERIMENTALproviders are trained to communicate with patients about adherence and patients are coached to discuss adherence with providers
Interventions
providers are trained to communicate with patients about adherence and patients are coached to discuss adherence with providers
Eligibility Criteria
You may qualify if:
- Currently providing primary care to at least 10 HIV-infected patients in the clinic
- Physician, Nurse-Practitioner, or Physician-Assistant
- Agree to give written informed consent.
- HIV-infected patient of one of the participating providers
- Has had at least one prior visit with that provider
- Currently taking antiretroviral therapy
- Capable of understanding and giving written informed consent
- Age \> 20 years old
- English-speaking
- African-American (or people of African descent living in the United States), Hispanic, or non-Hispanic White race/ethnicity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Wayne State University
Detroit, Michigan, 48201, United States
Saint Lukes-Roosevelt
New York, New York, 10023, United States
Oregon Health Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Catherine Beach, MD, MPH
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 7, 2008
First Posted
May 9, 2008
Study Start
May 1, 2008
Primary Completion
May 1, 2009
Study Completion
May 1, 2010
Last Updated
April 1, 2015
Record last verified: 2015-03